The OCTAVE trial is one of the largest studies in the world so far into post-SARS-CoV-2 vaccination in immunocompromised patients and is funded by the Medical Research Council (MRC). OCTAVE is a collaborative research project involving groups in the Universities of Glasgow, Birmingham, Oxford, Liverpool, Imperial College London and Leeds Teaching Hospitals NHS Trust.
For those with an interest - OCTAVE study in... - Vasculitis UK
For those with an interest - OCTAVE study initial findings reveal vaccine responses in patients with impaired immune systems
John_MillsVolunteer
Written by
John_Mills
Volunteer
To view profiles and participate in discussions please or .
Read more about...
3 Replies
•
Thanks John. I hope the medics are telling patients this before starting them on rituximab.
Thanks John for this, very interesting and worrying for those of us on rituximab. I will definitely be taking my third dose of the vaccine when I'm offered it and can only hope it will help if only to some extent. It's all very worrying still.
I had a conversation with my specialist earlier this year about being treated with a different immune suppressant which I think I will continue with in my next appointment as it feels to me like being on rituximab just leaves us in such a vulnerable position and covid doesn't look like it's going anywhere.
Not what you're looking for?
You may also like...
Third Vaccine / Covid 19 immune response
awaiting third vCivid vaccine. His concern is that he had both initial Covid vaccines whilst...
New Anti-viral treatments are here!
which the (Octave?) study showed to be the cohort with the least protection from the vaccination...
Study into the genetics of ANCA Associated Vasculitis
Interesting article about Arthritis Research funding a study into the genetics of ANCA Associated...
Your help is needed - Neuropathy Study
Hadden of Kings College Hospital, London has teamed with Professor Raashid Luqmani of Oxford to...
An update on where and what Vasculitis UK are about at the moment...
for a research study into fatigue in vasculitis patients at Birmingham. Also a study at University...